Brain Cancer
Glioblastoma of Brain Stem
Male, 32 years
Patient Internal 276057614
ICD-10 code
C71.7 Malignant Neoplasm of Brain Stem
Diagnosis (Incl. Metastases/Stage) and Year
May 2022
Glioblastoma of Brain Stem WHO Grade 3-4, IDH(-), ATRH(-), TP53(+), MGMT(-).
Previous Treatment
Surgery, Radiation Therapy and Chemotherapy (Temozolomide), Chemotherapy (Temozolomide), Chemotherapy (Lomustine).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~14 months from diagnosis.
Treatment Provided
Autologous DCV (7 doses) and CIK (4 doses) over a period of 7 months.
Patient Survival/Condition and Year
Date of Review: 07/02/2024
The patient survived for 13 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, benefitted the patient in almost meeting the median survival, however did not extended patient survival.
